Hyperbaric Oxygen Therapy in Diabetics With Chronic Foot Ulcers and Improvement of Quality of Life
Description:
OBJECTIVE – This study evaluated the effect of hyperbaric oxygen therapy (HBOT) on wound
healing, inflammation index, glycemic control, amputation rate, survival rate of tissue,
bacterial wound cultures, and quality of life (QOL) in diabetic foot ulcer (DFU) patients
with diabetes.
RESEARCH DESIGN AND METHODS – This study was a randomized, single-center clinical trial. The
effects of HBOT on patients in the experimental group were compared with the control group
received only routine care. HBOT was carried out in a hyperbaric chamber for 120-min per
session, five days a week for four consecutive weeks (20 treatment sessions). Data were
collected at 4 segments: pre-treatment (before first administration of HBOT; T1), during
treatment (at the tenth administration of HBOT; T2), post-treatment (at the twentieth
administration of HBOT; T3), and treatment follow-up (two weeks after the last therapy ended;
T4).
Condition:
Diabetic Foot Ulcer
Treatment:
Hyperbaric oxygen therapy
Start Date:
June 2011
Sponsor:
Chen-Yu Chen
For More Information:
https://clinicaltrials.gov/show/NCT02328508